Display options
Share it on

Exp Ther Med. 2018 Dec;16(6):4722-4728. doi: 10.3892/etm.2018.6772. Epub 2018 Sep 19.

Effects of androgen and progestin on the proliferation and differentiation of osteoblasts.

Experimental and therapeutic medicine

Xinchen Wu, Mengqi Zhang

Affiliations

  1. Department of Biomedical Engineering, Stevens Institute of Technology, Hoboken, NY 07030, USA.
  2. Department of Pediatrics, Peking Union Medical College Hospital, Beijing 100730, P.R. China.

PMID: 30542427 PMCID: PMC6257455 DOI: 10.3892/etm.2018.6772

Abstract

Osteoporosis is liable to affect patients with gonadal hormone deficiency, and a supplement of androgens may be used to increase bone density of patients with osteoporosis. Since the androgens currently used may cause severe side effects, it is useful to investigate the effect of other androgens and progestin on bone improvement. The aim of the current study was to investigate the effects of pregnenolone (Preg), androstenedione (AD), etiocholanolone (Etio), androsterone (An), nandrolone (NA) and testosterone (T) on the proliferation and differentiation of osteoblasts for potential clinical applications. Human osteoblasts were cultured and treated with androgens and progestin, including Preg, AD, Etio, An, NA, and T, at concentrations of 0, 10

Keywords: androgen; androstenedione; androsterone; etiocholanolone; nandrolone; osteoblasts; pregnenolone; testosterone

References

  1. Endocr Pract. 2012 Sep-Oct;18(5):758-62 - PubMed
  2. BJU Int. 2011 Nov;108(10):1634-9 - PubMed
  3. Endocrinology. 1997 Sep;138(9):4013-21 - PubMed
  4. Birth Defects Res B Dev Reprod Toxicol. 2014 Apr;101(2):168-77 - PubMed
  5. J Bone Miner Res. 1988 Feb;3(1):27-36 - PubMed
  6. J Urol. 2000 Jan;163(1):181-6 - PubMed
  7. J Steroid Biochem Mol Biol. 1995 Jun;53(1-6):165-74 - PubMed
  8. Cancer. 2004 Mar 1;100(5):892-9 - PubMed
  9. Semin Reprod Med. 2014 Nov;32(6):454-62 - PubMed
  10. J Mater Sci Mater Med. 2012 Nov;23(11):2751-9 - PubMed
  11. Steroids. 2009 Mar;74(3):296-305 - PubMed
  12. Panminerva Med. 2014 Jun;56(2):151-63 - PubMed
  13. Biochim Biophys Acta. 1968 Mar 1;150(2):173-80 - PubMed
  14. Front Horm Res. 2009;37:123-32 - PubMed
  15. J Clin Endocrinol Metab. 2012 Mar;97(3):E367-75 - PubMed
  16. Gen Comp Endocrinol. 1989 Oct;76(1):73-82 - PubMed
  17. Eur Heart J. 1996 Oct;17(10):1576-83 - PubMed
  18. Tissue Eng Part A. 2018 Nov;24(21-22):1603-1615 - PubMed
  19. Clin Dev Immunol. 2013;2013:575936 - PubMed
  20. Learn Mem. 2015 Aug 18;22(9):472-93 - PubMed
  21. Toxicol Lett. 2016 Sep 30;259:21-27 - PubMed
  22. Ther Clin Risk Manag. 2009 Jun;5(3):427-48 - PubMed
  23. Lab Invest. 2014 Jun;94(6):663-73 - PubMed
  24. Yonsei Med J. 2013 Nov;54(6):1331-5 - PubMed
  25. Am J Physiol Heart Circ Physiol. 2011 Apr;300(4):H1210-21 - PubMed
  26. Trends Mol Med. 2014 Aug;20(8):449-59 - PubMed
  27. Blood. 2011 Aug 11;118(6):1516-24 - PubMed
  28. Endocrinology. 1989 Mar;124(3):1576-8 - PubMed
  29. Endocrinol Metab Clin North Am. 2012 Sep;41(3):629-41 - PubMed
  30. Ann Intern Med. 1967 Dec;67(6):1268-95 - PubMed
  31. PLoS One. 2013;8(3):e60569 - PubMed
  32. Am J Sports Med. 1984 Jan-Feb;12(1):31-8 - PubMed
  33. Bone. 2016 Jan;82:42-9 - PubMed
  34. Menopause Int. 2011 Jun;17(2):63-5 - PubMed
  35. Lancet. 2011 Apr 9;377(9773):1276-87 - PubMed
  36. N Engl J Med. 1988 Apr 14;318(15):996 - PubMed
  37. Endocrinol Metab Clin North Am. 2012 Sep;41(3):475-86 - PubMed
  38. Biochem J. 2000 Oct 1;351(Pt 1):67-77 - PubMed
  39. Vet Comp Orthop Traumatol. 2017 Sep 12;30(5):351-356 - PubMed
  40. J Steroid Biochem Mol Biol. 2014 Jul;142:155-70 - PubMed
  41. Endocrine. 2014 Mar;45(2):165-77 - PubMed
  42. Epilepsia. 2005 Jun;46(6):819-27 - PubMed
  43. J Clin Endocrinol Metab. 2016 Sep;101(9):3497-505 - PubMed

Publication Types